MedTrace Logo

Effectiveness of SMS Invitation on Colorectal Cancer Screening on 45-49-Year-Olds

NCT07112729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6708

Last updated 2026-02-03

No results posted yet for this study

Summary

The goal of this study is to learn if sending text message invitations increases participation in colorectal cancer screening among 45-49 year olds in Yingge District, New Taipei City. It will also assess the effectiveness of this method. The main questions it aims to answer are:

•Does sending text message invitations increase the number of residents who complete fecal occult blood test (FOBT)? This study will compare a group receiving text message invitations to a control group receiving standard notifications to see if text messages are an effective way to increase screening rates.

Participants will:

* Be randomly assigned to either receive text message invitations or standard notifications.
* The intervention group will receive an initial text and a reminder text one week later.
* The control group will receive standard notifications, and after one month will receive the same text message.
* The study will track who obtains a FOBT kit and who completes the test within a three-month period.

Conditions

  • No Condition

Interventions

OTHER

Active SMS Invitation

Participants in this group will receive a text message inviting them to participate in the free FOBT program. The SMS message will include a brief explanation of the program, instructions on how to obtain a screening kit, and a contact number for inquiries. A reminder SMS message will be sent one week after the initial message.

Sponsors & Collaborators

  • Chang Gung University

    lead OTHER

Principal Investigators

  • Sherry Yueh-Hsia CHIU, PhD · Department of Health Care Management, Chang Gung University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-07
Primary Completion
2025-09-04
Completion
2025-09-18

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07112729 on ClinicalTrials.gov